| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2020NatCo..11.3581J |
| P356 | DOI | 10.1038/S41467-020-17488-8 |
| P698 | PubMed publication ID | 32665645 |
| P50 | author | Sheng-Ce Tao | Q90485050 |
| Dong Men | Q90725775 | ||
| He-Wei Jiang | Q97523385 | ||
| P2093 | author name string | Yang Li | |
| Wei Wang | |||
| Hua Li | |||
| Jie Zhou | |||
| Xiao Yang | |||
| Huan Qi | |||
| Hai-Nan Zhang | |||
| P2860 | cites work | Significance analysis of microarrays applied to the ionizing radiation response | Q24606608 |
| The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis | Q27001157 | ||
| Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus | Q28188496 | ||
| Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor | Q30219701 | ||
| SARS and MERS: recent insights into emerging coronaviruses | Q30249325 | ||
| SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome | Q30588597 | ||
| Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution | Q33627189 | ||
| Specific serology for emerging human coronaviruses by protein microarray | Q34339907 | ||
| Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan | Q34469966 | ||
| Severe acute respiratory syndrome diagnostics using a coronavirus protein microarray | Q34572875 | ||
| Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein | Q35159147 | ||
| Mycobacterium tuberculosis proteome microarray for global studies of protein function and immunogenicity | Q35511448 | ||
| SARS--beginning to understand a new virus | Q35701656 | ||
| Rapid Production of Virus Protein Microarray Using Protein Microarray Fabrication through Gene Synthesis (PAGES). | Q36222804 | ||
| Systematic identification of arsenic-binding proteins reveals that hexokinase-2 is inhibited by arsenic. | Q36371410 | ||
| Porcine deltacoronavirus nsp5 inhibits interferon-β production through the cleavage of NEMO. | Q40406558 | ||
| Recombinant protein-based enzyme-linked immunosorbent assay and immunochromatographic tests for detection of immunoglobulin G antibodies to severe acute respiratory syndrome (SARS) coronavirus in SARS patients. | Q40685865 | ||
| Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in sars patients by enzyme-linked immunosorbent assay. | Q41040035 | ||
| Systematic Identification of Mycobacterium tuberculosis Effectors Reveals that BfrB Suppresses Innate Immunity | Q41919760 | ||
| The crystal structure of ORF-9b, a lipid binding protein from the SARS coronavirus. | Q42691537 | ||
| SARS corona virus peptides recognized by antibodies in the sera of convalescent cases | Q43691969 | ||
| Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome | Q47742637 | ||
| Antibody responses to individual proteins of SARS coronavirus and their neutralization activities | Q47801038 | ||
| Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus | Q47877806 | ||
| Antibody responses against SARS-coronavirus and its nucleocaspid in SARS patients | Q47947942 | ||
| Metabolic engineering of long chain-polyunsaturated fatty acid biosynthetic pathway in oleaginous fungus for dihomo-gamma linolenic acid production | Q50900552 | ||
| Hosts and Sources of Endemic Human Coronaviruses | Q51146867 | ||
| Profile of specific antibodies to the SARS-associated coronavirus | Q51661106 | ||
| A toolbox of immunoprecipitation-grade monoclonal antibodies to human transcription factors | Q52594384 | ||
| A pneumonia outbreak associated with a new coronavirus of probable bat origin | Q84367633 | ||
| Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China | Q84574466 | ||
| A new coronavirus associated with human respiratory disease in China | Q84956787 | ||
| Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2 | Q87726414 | ||
| Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein | Q87973551 | ||
| SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor | Q88292103 | ||
| Generation of antibodies against COVID-19 virus for development of diagnostic tools | Q88974689 | ||
| Evaluation of Enzyme-Linked Immunoassay and Colloidal Gold- Immunochromatographic Assay Kit for Detection of Novel Coronavirus (SARS-Cov-2) Causing an Outbreak of Pneumonia (COVID-19) | Q88975354 | ||
| Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation | Q89108866 | ||
| Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China | Q89606309 | ||
| Development and Clinical Application of A Rapid IgM-IgG Combined Antibody Test for SARS-CoV-2 Infection Diagnosis | Q89913143 | ||
| Longitudinal serum autoantibody repertoire profiling identifies surgery-associated biomarkers in lung adenocarcinoma | Q89952897 | ||
| Convalescent plasma as a potential therapy for COVID-19 | Q89954633 | ||
| Diagnosis and Treatment Plan for COVID-19 (Trial Version 6) | Q90630898 | ||
| Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor | Q90738260 | ||
| Feline Infectious Peritonitis Virus Nsp5 Inhibits Type I Interferon Production by Cleaving NEMO at Multiple Sites | Q92443141 | ||
| Influenza Virus Infection Induces a Narrow Antibody Response in Children but a Broad Recall Response in Adults | Q92822357 | ||
| A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients | Q95269025 | ||
| P433 | issue | 1 | |
| P921 | main subject | immunoglobulin G | Q79448 |
| immunoglobulin M | Q79451 | ||
| proteomics | Q471857 | ||
| COVID-19 | Q84263196 | ||
| SARS-CoV-2 | Q82069695 | ||
| P304 | page(s) | 3581 | |
| P577 | publication date | 2020-07-14 | |
| P1433 | published in | Nature Communications | Q573880 |
| P1476 | title | SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses | |
| P478 | volume | 11 |
| Q100694024 | A high-stringency blueprint of the human proteome |
| Q98460311 | Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses |
| Q107379581 | Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray |
| Q99212171 | COVID-19 diagnostic testing: Technology perspective |
| Q131606622 | Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts |
| Q108158542 | Guiding the Design of Heterogeneous Electrode Microstructures for Li‐Ion Batteries: Microscopic Imaging, Predictive Modeling, and Machine Learning |
| Q99207660 | Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients |
| Q107338476 | Nsp2 has the potential to be a drug target revealed by global identification of SARS-CoV-2 Nsp2-interacting proteins |
| Q99400178 | On the genetics and immunopathogenesis of COVID-19 |
| Q106460748 | SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO |
| Q98164557 | SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70 |
| Q106513531 | The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis |
Search more.